ECL · Full Picture

ECOLAB INC. — the full picture

Earnings window · 2026-07-16 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Liquidity and Debt Position · Debt, leverage & refinancingPriority 85
    +44.9% cash (realized); structured_verified
    During the first six months of 2026, the company issued $5.1 billion of long-term debt; in the first six months of 2025 the company issued $500 million of long-term debt.
  2. Interest Rate and Refinancing Exposure · Interest ratesPriority 83
    -16.7% liability (realized); 2 forward row(s); quote_verified
    In July 2026 the company entered into cross-currency swap derivative contracts with aggregate notional amounts of CNH 3,385 million, €150 million and CAD 120 million designated as net investment hedges.
  3. Acquisitions and Partnerships · M&A and divestituresPriority 78
    +21.7% assets (realized); structured_verified
    Agreement to acquire CoolIT Systems for $4.75 billion announced March 20, 2026 and acquisition completed on July 2, 2026
  4. Segment Revenue Performance · Revenue growth & mixPriority 71
    +14.1% revenue (realized); 2 sources (news, sec_filing); quote_verified
    Fixed currency net sales for Global Life Sciences in Q2 2026 were $221.0 million and in Q2 2025 were $191.4 million.
  5. One Ecolab Restructuring · Restructuring & impairmentPriority 68
    -3.8% net_income; 6 forward row(s); structured_verified
    One Ecolab total anticipated restructuring costs are $328 million ($256 million after tax) or $0.90 per diluted share by the end of 2027.
  6. Operating Income and Margins · Operating income & profitabilityPriority 68
    +13.6% operating_income (realized); structured_verified
    Non-GAAP adjusted operating income for the first six months of 2026 was $1,488.7 million and for the first six months of 2025 was $1,326.8 million.
  7. Gross Margin Drivers · Gross marginPriority 60
    -3.3% operating_income; 1 forward row(s); structured_verified
    Product and equipment cost of sales for the second quarter ended June 30, 2026: $1,918.9 million and for the second quarter ended June 30, 2025: $1,728.4 million.
  8. Capital Return Program · Buybacks & dividendsPriority 58
    -2.4% cash (realized); 2 sources (news, sec_filing); 1 forward row(s); structured_verified
    The company repurchased shares totaling $669 million in the first six months of 2026 and $199 million in the first six months of 2025.
  9. FX / Currency Headwinds · Currency / FXPriority 57
    quote_verified
    Subsequent event: In July 2026 the Company entered into cross-currency swap derivative contracts with aggregate notional amount of CNH 3,385 million designated as net investment hedges of its Chinese Yuan exposures.
  10. Pest Elimination Demand · Demand, orders & backlogPriority 53
    quote_verified
    Global Pest Elimination organic operating income margins increased 0.9 percentage points in Q2 2026 as a 5.4 point positive impact from pricing, higher volume and improved productivity was partially offset by a 4.7 point impact from investments in the business.
  11. Operating Expense Trends · Operating expenses (SG&A)Priority 52
    quote_verified
    Second quarter 2026 selling, general and administrative expenses: $1,141.6 million
  12. Capital Expenditures · Capital expenditurePriority 51
    -2.6% cash (realized); structured_verified
    Cash used for investing activities was ($629.5) million in the first six months of 2026 and ($448.4) million in the first six months of 2025, a change of ($181.1) million.

Threads by pillar

Revenue & Demand Priority 80 · 5 threads

Costs & Margins Priority 84 · 4 threads

Capital & Balance Sheet Priority 92 · 6 threads

Strategy & Portfolio Priority 78 · 1 thread

Legal, Regulatory & Policy Priority 38 · 1 thread

Macro & Market Conditions Priority 88 · 3 threads

Unclassified Priority 45 · 2 threads

Expected impact by metric

metricforward netforward grossrealized
operating_income-4.4%+11.8%+3.8%
net_income-3.8%+3.8%+2.5%
cash——+40.1%
assets——+41.5%
margin——-0.7%
revenue——+14.1%
liability——-54.1%